Focus: Origin Sciences is a UK-based biotechnology company specializing in rectal/stool-sampling diagnostic devices for oncology applications. The company operates at an early-stage discovery phase with a focus on non-invasive sampling methodologies.
Profile data last refreshed 7h ago · AI intelligence enriched 1mo ago
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Best suited for scientists or engineers willing to accept early-stage risk in exchange for deep technical involvement in a potentially transformative diagnostic platform, but limited career growth options.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Origin Sciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Origin Sciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo